Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and caucasian patients

Journal of the American College of Cardiology

Volumn 33, Issue 6, 1999, Pages 1442-1452

  Beltrame, John F ^a,d   Sasayama, Shigetake ^b   Maseri, Attilio ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^d North Western Adelaide Health Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL REACTIVITY; CAUCASIAN; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; HUMAN; JAPAN; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS, VARIANT; ASIAN CONTINENTAL ANCESTRY GROUP; AUTONOMIC NERVOUS SYSTEM; CORONARY CIRCULATION; CORONARY VASOSPASM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITRIC OXIDE; VASOMOTOR SYSTEM;

EID: 0033133490     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00073-X     Document Type: Review

References (108)

1. Maseri A, Kaski J. Pathogenetic mechanisms of coronary artery spasm. J Am Coll Cardiol 1989;14:610-2.
2. Mashiba H, Hoshio A, Kotake H. Interaction between coronary artery tone and spasm. J Am Coll Cardiol 1991;17:1063-4.
3. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 1990;81:482-90.
4. Opie LH. Calcium channel antagonists in the management of anginal syndromes: changing concepts in relation to the role of coronary vasospasm. Prog Cardiovasc Dis 1996;38:291-314.
5. Pristipino C, Finocchiaro M, Beltrame J, et al. Differences in coronary vasospastic response after recent myocardial infarction in Japanese and Caucasian patients. Circulation 1997;96:I-534.
6. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation 1990;81: 1983-91.
7. Gould K, Lipscomb K. Effect of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974;34:48-55.
8. Caralis DG, Deligonul U, Kern MJ, Cohen JD. Smoking is a risk factor for coronary spasm in young women. Circulation 1992;85: 905-9.
9. Scholl JM, Benacerraf A, Ducimetiere P, et al. Comparison of risk factors in vasospastic angina without significant fixed coronary narrowing to significant fixed coronary narrowing and no vasospastic angina. Am J Cardiol 1986;57:199-202.
10. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-9.
11. Nobuyoshi M, Abe M, Nosaka H, et al. Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant. Am Heart J 1992;124:32-8.
12. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-7.
13. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
14. Brush JE Jr, Faxon DP, Salmon S, Jacobs AK, Ryan TJ. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol 1992;19:809-15.
15. Treasure CB, Manoukian SV, Klein JL, et al. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res 1992;71:776-81.
16. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
17. Crea F, Davies G, Romeo F, et al. Myocardial ischemia during ergonovine testing: different susceptibility to coronary vasoconstriction in patients with exertional and variant angina. Circulation 1984;69:690-5.
18. Okumura K, Yasue H, Matsuyama K, et al. Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 1988;12:883-8.
19. Maseri A, Chierchia S. Coronary artery spasm: demonstration, definition, diagnosis, and consequences. Prog Cardiovasc Dis 1982; 25:169-92.
20. Yasue H, Kugiyama K. Coronary artery spasm: Japanese view. Coron Artery Dis 1990;1:668-73.
21. Maseri A. Variant angina. Ischemic Heart Disease: A Rational Basis for Clinical Practice and Clinical Research. New York: Churchill Livingstone, 1995:559.
22. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. A variant form of angina pectoris: preliminary report. Am J Med 1959;27:375-88.
23. Cheng T, Bashour T, Kelser GJ, Weiss L, Bacos J. Variant angina of Prinzmetal with normal coronary arteriograms. A variant of the variant. Circulation 1973;47:476-85.
24. Yasue H, Omote S, Takizawa A, et al. Comparison of coronary arteriographic findings during angina pectoris associated with S-T elevation or depression. Am J Cardiol 1981;47:539-46.
25. Miwa K, Fujita M, Ejiri M, Sasayama S. Usefulness of intracoronary injection of acetylcholine as a provocative test for coronary artery spasm in patients with vasospastic angina. Heart Vessels 1991;6:96-101.
26. Nakamura M, Takeshita A, Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation 1987;75:1110-6.
27. Yasue H, Takizawa A, Nagao M, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation 1988;78:1-9.
28. Shimokawa H, Nagasawa K, Irie T, et al. Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between Western and Japanese populations. Int J Cardiol 1988;18:331-49.
29. Severi S, Davies G, Maseri A, Marzullo P, L'Abbate A. Long-term prognosis of "variant" angina with medical treatment. Am J Cardiol 1980;46:226-32.
30. Waters DD, Miller DD, Szlachcic J, et al. Factors influencing the long-term prognosis of treated patients with variant angina. Circulation 1983;68:258-65.
31. Mark DB, Califf RM, Morris KG, et al. Clinical characteristics and long-term survival of patients with variant angina. Circulation 1984; 69:880-8.
32. Walling A, Waters DD, Miller DD, Roy D, Pelletier GB, Theroux P. Long-term prognosis of patients with variant angina. Circulation 1987;76:990-7.
33. Kimura E, Kishida H. Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan. Circulation 1981;63: 844-8.
34. Koyanagi S, Takeshita A, Nakamura M. Clinical characteristics of sudden cardiac death in patients with vasospastic angina. Jpn Cire J 1989;53:1541-5.
35. Sheehan FH, Epstein SE. Determinants of arrhythmic death due to coronary spasm: effect of preexisting coronary artery stenosis on the incidence of reperfusion arrhythmia. Circulation 1982;65:259-64.
36. Yasue H, Okumura K. Clinical diagnosis of the pathogenesis of coronary spastic angina. Jpn J Med 1990;29:665-6.
37. Dunn RF, Kelly DT, Sadick N, Uren R. Multivessel coronary artery spasm. Circulation 1979;60:451-5.
38. Igarashi Y, Tamura Y, Tanabe Y, et al. Clinical and angiographic characteristics of patients with multivessel coronary spasm in variant angina. Significance of progressive course of angina and disease activity. Jpn Heart J 1994;35:419-30.
39. Onaka H, Hirota Y, Shimada S, et al. Clinical observation of spontaneous anginal attacks and multivessel spasm in variant angina pectoris with normal coronary arteries: evaluation by 24-hour 12-lead electrocardiography with computer analysis. J Am Coll Cardiol 1996;27:38-44.
40. Bell MR, Lapeyre AC, Bove AA. Angiographic demonstration of spontaneous diffuse three vessel coronary artery spasm. J Am Coll Cardiol 1989;14:523-7.
41. Crea F, Abela GS, Pepine CJ. Multivessel coronary spasm without electrocardiographic changes. Am Heart J 1985;110:1064-7.
42. Okumura K, Yasue H, Horio Y, et al. Multivessel coronary spasm in patients with variant angina: a study with intracoronary injection of acetylcholine. Circulation 1988;77:535-42.
43. Kadokami T, Shimokawa H, Fukumoto Y, et al. Coronary artery spasm does not depend on the intracellular calcium store but is substantially mediated by the protein kinase C-mediated pathway in a swine model with interleukin-1 beta in vivo. Circulation 1996;94: 190-6.
44. Marzilli M, Goldstein S, Trivella MG, Palumbo C, Maseri A. Some clinical considerations regarding the relation of coronary vasospasm to coronary atherosclerosis: a hypothetical pathogenesis. Am J Cardiol 1980;45:882-6.
45. MacAlpin RN. Contribution of dynamic vascular wall thickening to luminal narrowing during coronary arterial constriction. Circulation 1980;61:296-301.
46. Freedman B, Richmond DR, Kelly DT. Pathophysiology of coronary artery spasm. Circulation 1982;66:705-9.
47. Kaski JC, Tousoulis D, McFadden E, Crea F, Pereira WI, Maseri A. Variant angina pectoris. Role of coronary spasm in the development of fixed coronary obstructions. Circulation 1992;85:619-26.
48. Kaski J, Maseri A. Coronary artery spasm: European view. Coron Artery Dis 1990;1:660-7.
49. Yasue H, Touyama M, Shimamoto M, Kato H, Tanaka S. Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina. Circulation 1974;50:534-9.
50. Kugiyama K, Yasue H, Okumura K, et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996;94:266-72.
51. Hoshio A, Kotake H, Mashiba H. Significance of coronary artery tone in patients with vasospastic angina. J Am Coll Cardiol 1989;14: 604-9.
52. Kuga T, Egashira K, Inou T, Takeshita A. Correlation of basal coronary artery tone with constrictive response to ergonovine in patients with variant angina. J Am Coll Cardiol 1993;22:144-50.
53. Okumura K, Yasue H, Matsuyama K, et al. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. J Am Coll Cardiol 1996;27:45-52.
54. Yokoyama M, Akita H, Hirata K, et al. Supersensitivity of isolated coronary artery to ergonovine in a patient with variant angina. Am J Med 1990;89:507-15.
55. Hackett D, Larkin S, Chierchia S, Davies G, Kaski JC, Maseri A. Induction of coronary artery spasm by a direct local action of ergonovine. Circulation 1987;75:577-82.
56. Kaski JC, Tousoulis D, Gavrielides S, et al. Comparison of epicardial coronary artery tone and reactivity in Prinzmetal's variant angina and chronic stable angina pectoris. J Am Coll Cardiol 1991;17:1058-62.
57. Feldman R, Pepine C, Curry R, Conti C. Coronary arterial responses to graded doses of nitroglycerine. Am J Cardiol 1979;43:91-7.
58. Hill JA, Feldman RL, Pepine CJ, Conti CR. Regional coronary artery dilation response in variant angina. Am Heart J 1982;104:226-33.
59. Egashira K, Katsuda Y, Mohri M, et al. Basal release of endotheliumderived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol 1996;27:1444-9.
60. Kugiyama K, Ohgushi M, Motoyama T, et al. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1997;30:920-6.
61. Yoshimura M, Yasue H, Nakayama M, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998;103:65-9.
62. Egashira K, Inou T, Yamada A, Hirooka Y, Takeshita A. Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina. J Clin Invest 1992;89:1047-52.
63. Yamamoto H. Preserved endothelial function in the spastic segment of the human epicardial coronary artery in patients with variant angina - role of substance P in evaluating endothelial function. Eur Heart J 1993;14:118-22.
64. Kuga T, Egashira K, Mohri M, et al. Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo. Circulation 1995;92: 183-9.
65. Kugiyama K, Yasue H. Nitric oxide activity at the site of coronary spasm: deficient or preserved? Circulation 1997;96:1048-9.
66. Egashira K, Takeshita A. Nitric oxide activity at the site of coronary spasm: deficient or preserved? Circulation 1997;96:1048.
67. Yoshio H, Shimizu M, Sugihara N, et al. Assessment of autonomic nervous activity by heart rate spectral analysis in patients with variant angina. Am Heart J 1993;125:324-9.
68. Lanza GA, Pedrotti P, Pasceri V, Lucente M, Crea F, Maseri A. Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. J Am Coll Cardiol 1996;28:1249-56.
69. Waters DD, Miller DD, Bouchard A, Bosch X, Theroux P. Circadian variation in variant angina. Am J Cardiol 1984;54:61-4.
70. Lanza G, Patti G, Pasceri V, et al. Circadian variation of transient ischaemia in patients with variant angina with and without coronary stenoses. Circulation 1997;96:I-761.
71. Keys AE. Coronary heart disease in seven countries: summary. Circulation 1970;41:I:186-95.
72. Heart and Stroke Facts Report. Canberra: Australian National Heart Foundation, 1995.
73. Gordon T. Mortality experience among the Japanese living in the United States, Hawaii and Japan. Public Health Rep 1957;72:543-53.
74. Marmot MG, Syme SL, Kagan A, Kato H, Cohen JB, Belsky J. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. Am J Epidemiol 1975;102:514-25.
75. Simons LA. Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol 1986;57:5g-10g.
76. Worth R, Rhoads G, Kagan A, Kato H, Cohen J, Belsky J. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality. Am J Epidemiol 1975;102:481-90.
77. Saito M, Fukami K, Hiramori K, et al. Long-term prognosis of patients with acute myocardial infarction: is mortality and morbidity as low as the incidence of ischemic heart disease in Japan. Am Heart J 1987;113:891-7.
78. Nakamura Y, Kawai C, Moss AJ, et al. Comparison between Japan and North America in the posthospital course after recovery from an acute coronary event. Int J Cardiol 1996;55:245-54.
79. Bertrand ME, Lablanche JM, Tilmant PY, Thieuleux FA, Delforge MG, Chahine RA. The provocation of coronary arterial spasm in patients with recent transmural myocardial infarction. Eur Heart J 1983;4:532-5.
80. Mongiardo R, Finocchiaro ML, Beltrame J, et al. Low incidence of serotonin-induced occlusive coronary artery spasm in patients with recent myocardial infarction. Am J Cardiol 1996;78:84-7.
81. Okumura K, Yasue H, Matsuyama K, et al. Effect of acetylcholine on the highly stenotic coronary artery: difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery. J Am Coll Cardiol 1992;19:752-8.
82. Bertrand ME, LaBlanche JM, Tilmant PY, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982;65:1299-306.
83. Nosaka H, Nobuyoshi M. Coronary arterial spasm and symptomatology in ischemic and nonischemic heart diseases: study of the ergonovine maleate provocative test in 3,000 consecutive patients. J Cardiogr Suppl 1987;12:35-47.
84. Kanazawa K, Suematsu M, Ishida T, et al. Disparity between serotonin- and acetylcholine-provoked coronary artery spasm. Clin Cardiol 1997;20:146-52.
85. Suzuki Y, Tokunaga S, Ikeguchi S, et al. Induction of coronary artery spasm by intracoronary acetylcholine: comparison with intracoronary ergonovine. Am Heart J 1992;124:39-47.
86. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
87. Akiyama H, Ishikawa K, Kanamasa K, et al. Increased coronary vasomotor tone in acute myocardial infarction patients with spontaneous coronary recanalization. Jpn Cire J 1997;61:503-9.
88. DeWood MA, Stifter WF, Simpson CS, et al. Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med 1986;315:417-23.
89. Ganz W, Buchbinder N, Marcus H, et al. Intracoronary thrombolysis in evolving myocardial infarction. Am Heart J 1981;101:4-13.
90. Timmis GC, Gangadharan V, Hauser AM, Ramos RG, Westveer DC, Gordon S. Intracoronary streptokinase in clinical practice. Am Heart J 1982;104:925-38.
91. Anderson JL, Marshall HW, Bray BE, et al. A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med 1983;308:1312-8.
92. Leiboff RH, Katz RJ, Wasserman AG, et al. A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction. Am J Cardiol 1984;53:404-7.
93. Simoons ML, Serruys PW, v.d. Brand M, et al. Improved survival after early thrombolysis in acute myocardial infarction. A randomized trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet 1985;2:578-82.
94. Valentine RP, Pitts DE, Brooks Brunn JA, Williams JG, Van Hove E, Schmidt PE. Intravenous versus intracoronary streptokinase in acute myocardial infarction. Am J Cardiol 1985;55:309-12.
95. von Essen R, Uebis R, Schmidt W, et al. Intracoronary streptokinase in acute myocardial infarct. Experience with 461 patients. Dtsch Med Wochenschr 1985;110:570-5.
96. Messmer BJ, von Essen R, Minale C, et al. Intracoronary thrombolysis and early bypass surgery for acute myocardial infarct: five years' experience. Thorac Cardiovasc Surg 1986;34:1-4.
97. Steg PG, Himbert D, Benamer H, et al. Conservative management of patients with acute myocardial infarction and spontaneous acute patency of the infarct-related artery. Am Heart J 1997;134: 248-52.
98. Nakagawa S, Hanada Y, Koiwaya Y, Tanaka K. Angiographic features in the infarct-related artery after intracoronary urokinase followed by prolonged anticoagulation. Role of ruptured atheromatous plaque and adherent thrombus in acute myocardial infarction in vivo. Circulation 1988;78:1335-44.
99. Yasue H, Ogawa H, Okumura K. Coronary artery spasm in the genesis of myocardial ischemia. Am J Cardiol 1989;63:29e-32e.
100. Dote K, Sato H, Tateishi H, Uchida T, Ishihara M, Sasaki K. Clinical features of patients with spontaneous recanalization of the infarct-related artery during evolving acute myocardial infarction. J Cardiol 1989;19:729-39.
101. Betriu A, Pare JC, Sanz GA, et al. Myocardial infarction with normal coronary arteries: a prospective clinical-angiographic study. Am J Cardiol 1981;48:28-32.
102. Legrand V, Deliege M, Henrard L, Boland J, Kulbertus H. Patients with myocardial infarction and normal coronary arteriogram. Chest 1982;82:678-85.
103. Lindsay J Jr, Pichard AD. Acute myocardial infarction with normal coronary arteries (editorial). Am J Cardiol 1984;54:902-4.
104. Salem B, Haikal M, Zambrano A, Bollis A, Gowda S. Acute myocardial infarction with "normal" coronary arteries: clinical and angiographic profiles, with ergonovine testing. Tex Heart Inst J 1985;12:1-7.
105. Raymond R, Lynch J, Underwood D, Leatherman J, Razavi M. Myocardial infarction and normal coronary arteriography: a 10 year clinical and risk analysis of 74 patients. J Am Coll Cardiol 1988;11: 471-7.
106. Fukai T, Koyanagi S, Takeshita A. Role of coronary vasospasm in the pathogenesis of myocardial infarction: study in patients with no significant coronary stenosis. Am Heart J 1993;126:1305-11.
107. Horimoto M, Wakisaka A, Takenaka T, et al. Familial evidence of vasospastic angina and possible involvement of HLA-DR2 in susceptibility to coronary spasm. Jpn Cire J 1998;62:284-8.
108. Shimasaki Y, Yasue H, Yoshimura M, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998;31:1506-10.